TIMP2 and ovarian neoplasm: We propose that the growth and invasive functions of TIMP-2 in ovarian tumour biology in vitro is MMP-dependent and are regulated by MT1-MMP, while the chemosensitivity aspect may be dependent on chemotherapy-induced activation of the STAT3 pathway.